Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO/SLC7A11 pathway-Reference-Cited by-同舟云学术

Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO/SLC7A11 pathway

Published:2023-12 Issue: Volume:68 Page:102963
ISSN:2213-2317
Container-title:Redox Biology
language:en
Short-container-title:Redox Biology

Author:

Jiang Tianyu,Xiao Yao,Zhou Jinfeng,Luo Zupeng,Yu Lin,Liao Qichao,Liu Siqi,Qi Xinyi,Zhang Hao,Hou Menglong,Miao WeiWei,Batsaikhan Batbold,Damba Turtushikh,Liang Yunxiao,Li Yixing,Zhou Lei

Publisher

Elsevier BV

Subject

Organic Chemistry,Biochemistry,Clinical Biochemistry

Reference52 articles.

1. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review;Younossi;Hepatology,2023

2. Mitochondrial adaptation in nonalcoholic fatty liver disease: novel mechanisms and treatment strategies;Sunny;Trends Endocrinol. Metabol.,2017

3. Obesity and the liver: nonalcoholic fatty liver disease;Koppe;Transl. Res.,2014

4. Role of ferroptosis in non-alcoholic fatty liver disease and its implications for therapeutic strategies;Zhang;Biomedicines,2021

5. Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease;Tong;Acta Pharm. Sin. B,2022

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferroptosis promotes valproate-induced liver steatosis in vitro and in vivo;Food and Chemical Toxicology;2024-10

2. Targeting cell death in NAFLD: mechanisms and targeted therapies;Cell Death Discovery;2024-09-07

3. Liposome preparation of alpha-arbutin: stability and toxicity assessment using mouse B16F10 melanoma cells;Journal of Toxicology and Environmental Health, Part A;2024-09-02

4. Targeting the regulation of iron homeostasis as a potential therapeutic strategy for nonalcoholic fatty liver disease;Metabolism;2024-08

5. Insight into the regulatory mechanism of m6A modification: From MAFLD to hepatocellular carcinoma;Biomedicine & Pharmacotherapy;2024-08